Alamar Biosciences, Inc. (California) (ALMR)
28.05
+1.14
(+4.26%)
USD |
NASDAQ |
Nov 06, 16:00
28.07
+0.02
(+0.07%)
After-Hours: 20:00
Alamar Biosciences Research and Development Expense (Annual) : 37.47M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 37.47M |
| Date | Value |
|---|---|
| December 31, 2024 | 39.23M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Personalis, Inc. | 50.26M |
| 10X Genomics, Inc. | 238.63M |
| Champions Oncology, Inc. | 9.084M |
| Medpace Holdings, Inc. | -- |
| Avantor, Inc. | -- |